AI is helping patients fight insurance company denials

Published: Friday, July 18, 2025 at 10:00 am

AI Aids Patients in Battling Insurance Denials

Recent developments highlight the growing role of artificial intelligence in helping patients navigate the complex and often frustrating world of health insurance denials. One such case involves Stephanie Nixdorf, who, after battling Stage 4 melanoma, faced repeated denials for a crucial arthritis medication prescribed to combat side effects from her cancer treatment.

Nixdorf's doctors prescribed infliximab, but her insurance provider, Premera Blue Cross, denied coverage for nine months. This led to significant suffering for Nixdorf, impacting her ability to perform daily activities. Frustrated, her husband, Jason, sought help from Claimable Inc., a company utilizing AI to generate customized appeal letters. Claimable's AI platform analyzes clinical research and patient appeal histories to build a strong case for coverage. Using this system, Nixdorf's appeal letter, sent to Premera's executives and various government officials, resulted in the drug's approval within two days.

This case underscores a broader trend. Several companies are now offering AI-powered software to assist patients in crafting comprehensive appeal letters. These tools efficiently gather evidence of drug efficacy and past appeal successes, saving patients and their doctors valuable time.

The Nixdorf case also reveals potential issues within the insurance company's denial process. Premera cited a "processing error" and a misapplication of policy as the reasons for the initial denials. The Nixdorfs also raised concerns about the peer-to-peer review process, highlighting the involvement of a specialist lacking expertise in their specific medical conditions.

The challenges faced by patients in securing necessary medical care are further illustrated by a recent study. It found that insurers participating in marketplace plans under the Affordable Care Act denied a significant percentage of in-network claims, with a very low rate of appeals. When appeals were made, over half were upheld.

The use of AI in this context is not without its critics. However, the success of AI-driven appeal letters in overturning denials suggests a potential shift in the balance of power between patients and insurance companies.

BNN's Perspective:

While AI offers a promising tool for patients navigating insurance denials, it's crucial to address the underlying issues. Insurance companies must prioritize transparency, clear communication, and fair review processes. The use of AI should not be seen as a complete solution, but rather a tool to empower patients and ensure they receive the care they deserve.

Keywords: AI, insurance denials, health insurance, appeal letters, Premera Blue Cross, infliximab, arthritis, cancer treatment, Claimable Inc., Counterforce Health, patient advocacy, healthcare access, medical coverage, healthcare technology.

Full Story